NEW YORK (GenomeWeb) – OpGen announced today that it has partnered with Beth Israel Deaconess Medical Center (BIDMC) on a verification study for OpGen's Acuitas AMR Gene Panel u5.47 Assay and the Acuitas Lighthouse Knowledgebase. The study will be among the first to examine potential diagnostic and antibiotic decision-making improvements that may be possible using rapid molecular testing and bioinformatics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.